Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Charly & Phil Interview

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Feb 16, 2022 11:09pm

127 Views

Post# 34436633

RE:RE:RE:RE:RE:RE:Charly & Phil Interview

Merc-a-derp, portal vein injection has been a round forever. They've made people insulin free many times before. It's the defacto treatment aka the Edmonton protocol. Until they can do it using stem cells without immunosuppression, it's not a big deal and that's why the price is where it is.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario